95464-05-4 Purity
Pd ≥13.0%
If you have any other questions or need other size, please get a quote.
Specification
The molecular formula is C16H28BNO4.
The molecular weight is 309.2 g/mol.
It was created on September 16, 2005.
The IUPAC Name is tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylate.
The InChIKey is VVDCRJGWILREQH-UHFFFAOYSA-N.
It has 0 hydrogen bond donor count.
It has 4 hydrogen bond acceptor count.
The exact mass is 309.2111385 g/mol.
It has 3 rotatable bond count.
Yes, it is considered as a canonicalized compound.
Reference: [1]Current Patent Assignee: SANTHERA PHARMACEUTICALS HOLDING AG - EP1842846, 2007, A1
Location in patent: Page/Page column 40-41
[2]Location in patent: scheme or table
Gray, David L.; Xu, Wenjian; Campbell, Brian M.; Dounay, Amy B.; Barta, Nancy; Boroski, Susan; Denny, Lynne; Evans, Lori; Stratman, Nancy; Probert, Al
[Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 23, p. 6604 - 6607]
[3]Current Patent Assignee: SANTHERA PHARMACEUTICALS HOLDING AG - EP1826201, 2007, A1
Location in patent: Page/Page column 29
* For details of the synthesis route, please refer to the original source to ensure accuracy.